Ciclosporin A Cationic Emulsion 0.1% for the Management of Dry Eye Disease: Facts That Matter for Eye-Care Providers

Author:

Labetoulle Marc1ORCID,Leonardi Andrea2ORCID,Pisella Pierre-Jean3ORCID,Baudouin Christophe4ORCID

Affiliation:

1. Department of Ophthalmology, Paris-Sud University, Paris, France

2. Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy

3. Department of Ophthalmology, Bretonneau University Hospital, Tours, France

4. Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital and Vision Institute, IHU FOReSIGHT, Paris, France

Funder

Santen SA. Ana Tadeu of OPEN Health Communications (London, UK) provided writing, editorial, and formatting support

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Reference34 articles.

1. European Medicines Agency. Ikervis. European public assessment report 2015 updated 16/06/2021. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/ikervis.

2. US FDA. Drug approval package. Restasis cyclosporine ophthalmic emulsion 2005. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-023_Restasis.cfm.

3. Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye

4. TFOS DEWS II Management and Therapy Report

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Refractive surgery and dry eye - An update;Indian Journal of Ophthalmology;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3